Gnosis personnel presented two posters at the World Conference on Lung Cancer 2017, held in Yokohama, Japan, from the 15th to the 18th of October.
The first poster illustrates a new stratification model for identifying subjects at high risk of developing lung cancer, and that should undergo further clinical assessment. Massive application of this model on the general population would allow the identification of a large fraction of diseases that currently go unnoticed until a quite late stage.
Our second work introduces a signature composed by 4 blood metabolites that is potentially able to provide an early diagnosis for lung cancer. This signature would help clinician in diagnosing lung cancer in the earliest stages. Further studies are currently under preparation for validating this finding.